TRIAN FUND MANAGEMENT, L.P.: GE HEALTHCARE TECHNOLOGIES I (GEHC): Quarterly 13F Position History
As of Q2 2026, TRIAN FUND MANAGEMENT, L.P. reported 3,085,344 shares of GE HEALTHCARE TECHNOLOGIES I (GEHC), worth $197.5M and representing 4.7% of its 13F equity book. Quarter-over-quarter share count change: + 3,081,300 (+76194.4%) . The position first appeared in Q1 2023 and has been disclosed across 14 13F-HR filings in Pactolio's tracked window.
- 3,085,344Shares Held (Latest Filing)
- $197.5MReported Market Value (Latest Filing)
- 4.7%Portfolio Weight (% of 13F Equity Book)
- +3,081,300Quarter-over-Quarter Share Change
- +$197.2MQuarter-over-Quarter Value Change
- 3,085,344Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 14 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 3,085,344 | +3,081,300 | +76194.4% | $197.5M | 4.7% | $64.0 |
| Q1 2026 | 4,044 | 0 | – | $287.9K | 0.0% | $71.2 |
| Q4 2025 | 4,044 | +15 | +0.4% | $331.7K | 0.0% | $82.0 |
| Q3 2025 | 4,029 | 0 | – | $302.6K | 0.0% | $75.1 |
| Q2 2025 | 4,029 | 0 | – | $298.4K | 0.0% | $74.1 |
| Q1 2025 | 4,029 | 0 | – | $325.2K | 0.0% | $80.7 |
| Q4 2024 | 4,029 | 0 | – | $315.0K | 0.0% | $78.2 |
| Q3 2024 | 4,029 | 1,338,804 | -99.7% | $378.1K | 0.0% | $93.9 |
| Q2 2024 | 1,342,833 | 0 | – | $104.6M | 2.6% | $77.9 |
| Q1 2024 | 1,342,833 | 0 | – | $122.1M | 1.5% | $90.9 |
| Q4 2023 | 1,342,833 | +3 | +0.0% | $103.8M | 1.5% | $77.3 |
| Q3 2023 | 1,342,830 | 0 | – | $91.4M | 1.4% | $68.0 |
| Q2 2023 | 1,342,830 | 0 | – | $109.1M | 2.8% | $81.2 |
| Q1 2023 | 1,342,830 | – | – | $110.2M | 2.9% | $82.0 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did TRIAN FUND MANAGEMENT, L.P. first disclose a GEHC position in 13F-HR filings?
TRIAN FUND MANAGEMENT, L.P. first reported GE HEALTHCARE TECHNOLOGIES I (GEHC) on its 13F-HR filing for the period ending 2023-03-31 (Q1 2023). The position has appeared on 14 reported quarters within Pactolio's tracked window.
What was TRIAN FUND MANAGEMENT, L.P.'s most recent quarter-over-quarter share-count change in GEHC?
Between Q1 2026 and Q2 2026, TRIAN FUND MANAGEMENT, L.P. added 3,081,300 shares of GEHC (+76194.4%), bringing the total reported position to 3,085,344 shares at a market value of $197.5M.
Does the implied price-per-share represent TRIAN FUND MANAGEMENT, L.P.'s cost basis in GEHC?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.